Longterm remission of more than 5 years in a patient with progressive multifocal leucoencephalopathy and sarcoidosis

Reversal of Scleroderma Renal Crisis for

Reversal of Scleroderma Renal Crisis for More Than Two Years in a Patient Treated with Captopril

✍ Leif B. Sorensen; Kathryn Paunicka; Max Harris 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB 👁 2 views

Scleroderma renal crisis is perhaps the most dreaded manifestation of scleroderma. Until recently this complication was regarded as invariably fatal within 3 months after its onset. In the late 1970s isolated case reports suggesting that aggressive antihypertensive treatment may successfully control

The incidence and management of osteopor

The incidence and management of osteoporosis, gout, and avascular necrosis in recipients of renal allografts functioning more than 20 years (level 5A) treated with prednisone and azathioprine

✍ W.E Braun; B.J Richmond; D.A Protiva; R.W Gifford Jr; R.A Straffon 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Regression of intestinal metaplasia to c

Regression of intestinal metaplasia to cardiac or fundic mucosa in patients with Barrett's esophagus submitted to vagotomy, partial gastrectomy and duodenal diversion. A prospective study of 78 patients with more than 5 years of follow up

✍ Attila Csendes; Italo Bragheto; Patricio Burdiles; Gladys Smok; Ana Henriquez; F 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Doxorubicin versus methotrexate both com

Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer—a randomised study with more than 10 years follow-up from the danish breast cancer cooperative group

✍ M Andersson; E Lindegaard Madsen; M Overgaard; C Rose; P Dombernowsky; H.T Mouri 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Doxorubicin versus methotrexate both com

Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer—a randomised study with more than 10 years follow-up from the danish breast cancer cooperative group

✍ M Andersson; E Lindegaard Madsen; M Overgaard; C Rose; P Dombernowsky; H.T Mouri 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 117 KB

To evaluate the substitution of methotrexate with doxorubicin (Dox) in CMF-(cyclophosphamide, methotrexate, 5-fluorouracil) containing regimen for advanced breast cancer, 415 postmenopausal patients below the age of 66 years, naïve to chemotherapy, were accrued from 1980 to 1984 and followed-up unti

Sustained remissions and low rate of BCR

Sustained remissions and low rate of BCR-ABL resistance mutations with imatinib treatment chronic myelogenous leukemia in patients treated in late chronic phase: A 5-year follow up

✍ Georg Hess; Ralf G. Meyer; Brigitte Schuch; Katja Bechthold; Ilse El-Kholy; Chri 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB 👁 3 views